3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Wilms Tumor
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Pleuropulmonary blastoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Breast Neoplasms
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Tacrolimus
2
Surveys and Questionnaires
2
Proton Therapy
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Music Therapy
2
Mesna
2
Melphalan
2
Interviews as Topic
2
Gene Expression Profiling
2
Cyclophosphamide
2
Busulfan
2
tremelimumab
1
motesanib diphosphate
1
luprolide acetate gel depot
1
liposomal amphotericin B
1
durvalumab
1
copanlisib
1
chlorhexidine gluconate
1
batifiban
1
Whole Genome Sequencing
1
Watchful Waiting
1
Thrombopoietin
1
Taxes
1
Spermine Synthase
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Neoplasms
×
Ado-Trastuzumab Emtansine
×
Clear all
NCT04042051
2025-07-22
Panthera
Cancer Trials Ireland
Phase 1
Terminated
2 enrolled